Your browser is no longer supported. Please, upgrade your browser.
Settings
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-3.81 Insider Own2.70% Shs Outstand1.12B Perf Week13.27%
Market Cap8.93B Forward P/E3.17 EPS next Y2.51 Insider Trans0.67% Shs Float1.05B Perf Month26.03%
Income-3971.00M PEG- EPS next Q0.58 Inst Own59.40% Short Float6.82% Perf Quarter-3.64%
Sales17.72B P/S0.50 EPS this Y87.00% Inst Trans-4.68% Short Ratio3.38 Perf Half Y-51.91%
Book/sh12.93 P/B0.61 EPS next Y5.96% ROA-6.50% Target Price9.78 Perf Year-64.23%
Cash/sh1.92 P/C4.13 EPS next 5Y-3.10% ROE-27.90% 52W Range6.07 - 25.13 Perf YTD-48.51%
Dividend- P/FCF106.32 EPS past 5Y-28.50% ROI-3.20% 52W High-68.40% Beta1.77
Dividend %- Quick Ratio0.60 Sales past 5Y-1.50% Gross Margin43.10% 52W Low30.81% ATR0.52
Employees42535 Current Ratio1.00 Sales Q/Q-7.70% Oper. Margin-20.60% RSI (14)57.88 Volatility7.23% 6.63%
OptionableYes Debt/Eq2.03 EPS Q/Q-166.50% Profit Margin-22.60% Rel Volume0.92 Prev Close8.18
ShortableYes LT Debt/Eq1.84 EarningsAug 07 BMO Payout- Avg Volume21.12M Price7.94
Recom2.90 SMA2011.03% SMA503.55% SMA200-40.76% Volume19,437,998 Change-2.93%
Aug-07-19Downgrade Evercore ISI Outperform → In-line
Jul-19-19Initiated Wolfe Research Peer Perform
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-10-19Resumed Credit Suisse Neutral
Jul-05-19Upgrade Argus Hold → Buy
Jun-11-19Initiated Barclays Underweight $8
Jun-03-19Upgrade Oppenheimer Perform → Outperform $12
May-30-19Downgrade BofA/Merrill Buy → Underperform
May-28-19Downgrade UBS Buy → Neutral
Mar-20-19Initiated SunTrust Hold
Mar-07-19Resumed UBS Buy $22
Mar-06-19Downgrade Morgan Stanley Overweight → Equal-Weight $17
Feb-20-19Downgrade Mizuho Buy → Neutral $25 → $18
Feb-14-19Upgrade Raymond James Mkt Perform → Outperform $22
Jan-23-19Upgrade UBS Neutral → Buy
Jan-23-19Upgrade Piper Jaffray Underweight → Neutral
Jan-03-19Upgrade BofA/Merrill Underperform → Buy
Nov-05-18Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-01-18Upgrade Leerink Partners Underperform → Mkt Perform
Sep-21-18Resumed Oppenheimer Perform
Sep-13-19 04:54PM  The Week In Cannabis: Big Pharma Makes Moves, Diddy & Wahlberg Go After CBD, Medicine Man Continues M&A Spree Benzinga
10:17AM  The Zacks Analyst Blog Highlights: Berkshire Hathaway, Apple, American Express, Kraft Heinz and Teva Pharmaceutical Zacks
08:14AM  Teva Dips Into Medical Marijuana Market With Canndoc Distribution Deal Benzinga
05:00AM  INTERCURE: CANNDOC signs strategic distribution agreement with S.L.E. of TEVA Pharmaceuticals PR Newswire
Sep-12-19 10:59AM  Buffett's Best & Worst Performing Stocks Thus Far in 2019 Zacks
Sep-11-19 04:06PM  Francis Chou's Chou Europe Fund Semi-Annual 2019 Commentary GuruFocus.com
12:13PM  Mallinckrodt to Divest Contract Manufacturing Unit, Stock Up Zacks
Sep-09-19 05:28PM  Mallinckrodt (MNK) to Resolve Opioid Cases with Ohio Counties Zacks +6.13%
11:21AM  Novartis Announces Positive Long-Term Data on Migraine Drug Zacks
Sep-08-19 11:20PM  Here's Why Teva Pharmaceuticals Dropped 13% in August Motley Fool
Sep-06-19 01:22PM  These Are Buffett's Worst-Performing Stocks of 2019 GuruFocus.com
11:55AM  Opioid Crisis Fallout Earns Short-Sellers an $880 Million Payday Bloomberg
08:08AM  Mallinckrodt Mulls Bankruptcy Ahead of Major Opioid Litigation Zacks
Sep-05-19 04:36PM  Pharma Stock Crashes 39% On Potential Bankruptcy Amid Opioid Crisis Investor's Business Daily
09:00AM  Pfizer Stock Is A Top Pharma Company But Should You Buy It? Investor's Business Daily
Sep-04-19 04:22PM  Why The Opioid Epidemic Just Got More Complicated For Generic Pharmas Investor's Business Daily
04:14PM  Teva to Present New Analyses of Fremanezumab Efficacy and Safety in Adult Patients with Difficult-to-Treat Migraine at 19th Congress of the International Headache Society Business Wire
02:00AM  What Opioid Litigation Means for Healthcare Stocks Morningstar
Sep-03-19 04:05PM  Teva Announces United States Department of Commerce Appointment of Brendan OGrady to Investment Advisory Council Business Wire
11:04AM  Bayer, Teva Show Antitrust Law May Be Unnecessary GuruFocus.com
06:06AM  These 4 Stocks Have Cost Warren Buffett More Than $6 Billion in 2019 Motley Fool
Sep-02-19 09:41AM  Allergan Settles Ahead of Multi-District Opioid Litigation Zacks
Aug-30-19 04:20PM  Value Idea Contest Update: August GuruFocus.com
08:04AM  Novartis' (NVS) MS Drug Achieves Goals in Late-Stage Studies Zacks
08:00AM  Will Opioid Litigation Take its Toll on Pharma Companies? Zacks
Aug-29-19 11:34AM  'Public nuisance really just sounds bad': What the $572 million J&J fine means for opioid litigation Yahoo Finance
Aug-28-19 04:29PM  What Purdue's Rumored Deal Means For Other Opioid-Tied Pharmas Investor's Business Daily
04:13PM  J&J (JNJ) Loses Landmark Opioid Case: What's Next for Pharmaceuticals? Zacks
10:21AM  AstraZeneca's Fasenra Gets Orphan Drug Status for New Disease Zacks
09:26AM  Analysts view Johnson & Johnsons $572 million fine as a win MarketWatch
Aug-27-19 04:27PM  The J&J Opioid Lawsuit Could Let the Real Culprits Off the Hook Bloomberg -9.57%
04:14PM  Why The Opioid Verdict Is Actually A 'Devastating Body Blow' For J&J Investor's Business Daily
03:24PM  Why The Opioid Verdict Is Actually A 'Devastating Body Blow' For J&J Investor's Business Daily
01:11PM  Stocks - Skeptical Investors Push Wall Street Stocks Lower; Bonds Climb Investing.com
12:40PM  J&J Opioid Ruling 2019: 13 Things to Know InvestorPlace
12:13PM  Opioid Makers Sink as Traders Assess J&J Ruling Consequences Bloomberg
11:14AM  J&J to Pay $572M in Opioid Case; Plus Case-Shiller Home Price Read Zacks
11:01AM  J&J Up Despite $572M Fine in Oklahoma Opioid Abuse Case Zacks
10:40AM  Case-Shiller Index Nudges Up Zacks
08:44AM  3 Big Stock Charts for Tuesday: TechnipFMC PLC, Vertex Pharmaceuticals and Constellation Brands InvestorPlace
05:25AM  Purdue and Sacklers offer to settle opioid suits for up to $12bn Financial Times
Aug-26-19 04:56PM  Pharma Giant J&J Must Pay $572 Million For Oklahoma Opioid Crisis Investor's Business Daily +5.25%
Aug-23-19 02:37PM  Will Lawsuits Sink Johnson & Johnson Stock? InvestorPlace
10:15AM  J&J's (JNJ) Opioid Lawsuit Verdict in Oklahoma Due Next Week Zacks
09:40AM  Pharma Stock Roundup: ABBV's Rinvoq Gets FDA Nod, BAYRY to Sell Animal Health Unit Zacks
Aug-22-19 12:35PM  MiMedx Has Changed, But Its Critics Havent Bloomberg
11:08AM  Jim Cramer Weighs In On Pfizer, Teva And More Benzinga
11:08AM  BeiGene's NDA for Zanubrutinib Gets Priority Review From FDA Zacks
07:42AM  Mallinckrodt (MNK) Stock Down 70.8% YTD on Numerous Lawsuits Zacks
Aug-21-19 04:15PM  Opioid Epidemic: Will Pharmas Scramble To Settle As Landmark Case Looms? Investor's Business Daily +6.28%
01:38PM  Endo Up on Settlement of a Few Cases Related to Opioid Drugs Zacks
11:29AM  Oklahoma judge to rule on Monday in opioid lawsuit against J&J Reuters
11:04AM  Teva Launches Generic Version of Mylan's EpiPen for KIds Zacks
08:42AM  Shares of Teva up 3% on positive migraine trial MarketWatch
08:21AM  3 Warren Buffett Stocks to Buy Right Now Motley Fool
08:00AM  Fremanezumab Data in The Lancet Demonstrate Clinically Meaningful Reduction in Monthly Migraine Days Versus Placebo for Patients with Difficult-To-Treat Migraine Business Wire
05:54AM  Teva Rises on Positive Test Results for Migraine Treatment TheStreet.com
Aug-20-19 03:15PM  CLASS ACTION UPDATE for VNTR, TEVA and NFLX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:00AM  SHAREHOLDER ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Alerts Stockholders of Class Action and Lead Plaintiff Deadline: August 20, 2019 PR Newswire
09:21AM  SHAREHOLDER ALERT: TEVA EGBN CAH EVH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
08:38AM  INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
08:23AM  Teva to launch generic version of EpiPen for young children Reuters
08:09AM  Teva says FDA-approved generic EpiPen is now available in the U.S. for $300 for a 2-pack MarketWatch
08:00AM  Teva Announces Availability of a Generic Equivalent of EpiPen Jr® (epinephrine injection, USP) Auto-Injector, 0.15 mg in the United States Business Wire
06:06AM  Warren Buffett's Portfolio Yields a Big Surprise Motley Fool
05:31AM  [video]Teva's Generic EpiPen Jr Is Now Available for $300 TheStreet.com
Aug-19-19 10:50PM  TEVA 24 Hour Deadline Alert: Approximately 24 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA GlobeNewswire
04:50PM  CLASS ACTION UPDATE for BUD, TEVA and VERB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:53PM  FINAL DEADLINE: Rosen, a Globally Recognized Law Firm, Reminds Teva Pharmaceutical Industries Ltd. Investors of Important August 20th Deadline in Securities Class Action TEVA GlobeNewswire
12:25PM  CLASS ACTION UPDATE for TEVA, RBGLY and CURLF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:27AM  DEADLINE ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: August 20, 2019 ACCESSWIRE
09:42AM  CLASS ACTION UPDATE for TEVA, FDX, NFLX and KPTI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
08:30AM  TUESDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Aug-18-19 12:08PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of TEVA, CAH and NTAP ACCESSWIRE
Aug-16-19 10:50PM  TEVA 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA Business Wire
03:45PM  SHAREHOLDER ALERT: TEVA NGHC GVA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:00PM  DEADLINE ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: August 20, 2019 GlobeNewswire
01:27PM  Zhang Investor Law Reminds Investors of August 20 Deadline in Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. TEVA GlobeNewswire
12:40PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TEVA, VERB and NFLX ACCESSWIRE
10:26AM  INVESTOR ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: August 20, 2019 ACCESSWIRE
09:41AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TEVA, GTT, GVA and EVH GlobeNewswire
09:35AM  Should Value Investors Pick Teva Pharmaceutical (TEVA) Now? Zacks
Aug-15-19 11:05PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
10:38AM  Teva shares tumble amid political battle, doubt from Moody's Yahoo Finance
09:48AM  Drug Stocks Sank After 2 Members of Congress Reopened a Price-Fixing Inquiry Barrons.com
06:30AM  How to Extract Pretty Profits from Ugly Stocks TheStreet.com
Aug-14-19 02:30PM  US STOCKS-U.S. stocks stumble on fears of looming recession Reuters -10.51%
02:30PM  Teva's stock tumbles toward 20-year low; Moody's turns negative on drugmaker's 'junk'-rated debt MarketWatch
01:56PM  Lawmakers want more answers from Mylan over drug pricing probe American City Business Journals
12:16PM  Generic-Drug Giants Accused of Blocking Congressional Probe Bloomberg
11:00AM  SHAREHOLDER ALERT: TEVA FDX DBD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:25AM  INVESTOR ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Reminds Stockholders of Class Action and Lead Plaintiff Deadline: August 20, 2019 ACCESSWIRE
09:03AM  Teva Pharmaceutical Finance Netherlands IV BV -- Moody's affirms Teva's Ba2 CFR; outlook revised to negative Moody's
07:23AM  UPDATE 3-U.S. lawmakers push Mylan, Teva over drug pricing probe Reuters
06:28AM  U.S. lawmakers push Mylan, Teva over drug pricing probe -statement Reuters
Aug-13-19 11:12AM  Jazz (JAZZ) Acquires Cavion, Adds Movement Disorder Candidate Zacks
10:03AM  5 Top Value Stocks to Buy Now Motley Fool
09:52AM  CLASS ACTION UPDATE for PVTL, BUD, TEVA and CTST: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
08:50AM  7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Aug-12-19 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS BUD, EROS, RBGLY, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Daniell RichardExec. VP, European CommercialSep 09Sale7.163332,384363Sep 11 06:58 AM
BARER SOL JDirectorJun 04Buy9.60104,5001,003,409220,442Jun 05 07:02 AM
BARER SOL JDirectorJun 03Buy8.98111,000997,013115,942Jun 03 11:21 AM
de Notaristefani CarloExecutive VP Global OperationsMay 20Sale11.4216,070183,51933,589May 21 06:38 AM
de Notaristefani CarloExecutive VP Global OperationsMay 16Sale11.766297,39718,784May 20 07:18 AM
O'Grady Brendan P.EVP, North America CommercialMar 18Sale16.631,17919,6011,388Mar 19 08:29 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 18Sale16.643205,3269,002Mar 19 08:17 AM
Daniell RichardExec. VP, European CommercialMar 18Sale16.641,29721,5880Mar 19 08:14 AM
Stark David MatthewExec. VP Chief Legal OfficerMar 18Sale16.432,35838,7422,974Mar 19 08:11 AM
McClellan Michael JamesEVP, Chief Financial OfficerMar 18Sale16.632303,82412,760Mar 19 08:08 AM
Griffin Deborah AChief Accounting OfficerMar 18Sale16.6394315,6770Mar 19 08:06 AM
Fridriksdottir HafrunExecutive VP, Global R&DMar 18Sale16.633565,91916,750Mar 19 08:04 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 18Sale16.6363210,5079,149Mar 19 08:02 AM
Stark David MatthewExec. VP Chief Legal OfficerMar 12Sale15.822,44438,6642,974Mar 14 07:44 AM
O'Grady Brendan P.EVP, North America CommercialMar 12Sale15.6773811,5681,388Mar 14 07:41 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 12Sale15.693255,0998,450Mar 14 07:36 AM
Griffin Deborah AChief Accounting OfficerMar 12Sale15.6795314,9380Mar 14 07:33 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 12Sale15.6764710,1428,602Mar 14 07:31 AM
Daniell RichardExec. VP, European CommercialMar 12Sale15.6971511,2180Mar 14 07:28 AM
O'Grady Brendan P.EVP, North America CommercialMar 04Sale16.881,16619,6861,388Mar 05 07:36 AM
McClellan Michael JamesEVP, Chief Financial OfficerMar 04Sale16.883636,12912,330Mar 05 07:28 AM
Griffin Deborah AChief Accounting OfficerMar 04Sale16.884,10769,3400Mar 05 07:23 AM
Fridriksdottir HafrunExecutive VP, Global R&DMar 04Sale16.884096,90516,094Mar 05 07:16 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 04Sale16.8860610,2318,058Mar 05 07:10 AM
Daniell RichardExec. VP, European CommercialMar 04Sale16.882,09835,4230Mar 05 07:05 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 04Sale16.885128,6457,892Mar 05 08:20 AM
Stark David MatthewExec. VP Chief Legal OfficerFeb 14Sale17.743,92669,6472,974Feb 19 07:26 AM
de Notaristefani CarloExecutive VP Global OperationsFeb 14Sale17.673,19256,39918,209Feb 19 07:05 AM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 14Sale17.671,84132,52915,338Feb 19 07:11 AM
de Notaristefani CarloExecutive VP Global OperationsFeb 13Sale17.885,04190,10812,121Feb 14 07:43 AM
Fridriksdottir HafrunExecutive VP, Global R&DJan 02Sale15.701,64325,79911,826Jan 03 07:24 AM
Fridriksdottir HafrunExecutive VP, Global R&DNov 30Sale21.7693320,3048,829Dec 04 08:09 AM
McClellan Michael JamesEVP, Chief Financial OfficerNov 05Sale22.733467,86511,644Nov 07 06:38 AM
O'Grady Brendan P.EVP, North America CommercialSep 18Sale23.711,24129,4201,388Sep 20 04:10 PM
Nazzi GianfrancoEVP, Growth Markets CommercialSep 18Sale23.691,37932,6707,005Sep 20 04:09 PM
Griffin Deborah AChief Accounting OfficerSep 18Sale23.712,37656,3280Sep 20 04:08 PM
Dethlefs SvenEVP Global Marketing&PortfolioSep 18Sale23.7162514,8177,265Sep 20 04:06 PM
Daniell RichardExec. VP, European CommercialSep 18Sale23.692,48858,9430Sep 20 04:04 PM